Researchers & Healthcare Professionals

Administration & Management of Current Therapies for Hematologic Malignancies

Held in conjunction with the Oncology Nursing Society 38th Annual Congress.

Date: Saturday, April 27, 2013
CE Credit Available Until: January 12, 2015
Location: Walter E. Washington Convention Center, Ballroom A & B, Washington, DC
Target Audience: This activity has been designed to meet the education needs of nurses, social workers and other healthcare professionals involved in the care of patients living with hematologic cancers.
Access: Virtual Lecture

Program Goal

Oncology nursing management includes thorough knowledge of drug administration and awareness of adverse effects, including those that may cause serious and life-threatening issues. Nurses must be not only knowledgeable about administering medicines and managing possible reactions, it is also important for nurses to initiate and foster ongoing communication about side effects management and treatment adherence with both other treatment team members and with patients.

With a number of new hematologic cancer drug approvals, as well as new indications, or newly approved methods of administration for approved drugs, continuing nursing education is essential.

Through discussion of case studies, this symposium will provide the opportunity for nurses to build their knowledge about administering some of the current therapies used to treat hematologic malignancies. Monitoring and managing possible serious reactions, including infection, and communications among nurses, other treatment team members, and patients will be discussed.


At the conclusion of this program, participants should be able to:

  • List three new drugs/new applications of drugs to treat patients with blood cancer
  • Explain methods of administration for two new drugs to treat patients with blood cancer
  • Describe the importance of monitoring side effects and treatment adherence
  • Identify management of two potential treatment side effects
  • Identify two communication touchpoints on side effects management and treatment adherence for nurses and patients


Kevin Brigle, PhD, ANP
Oncology Nurse Practitioner
Massey Cancer Center
Virginia Commonwealth University Health System
Richmond, VA

Amy Goodrich, ACNP-BC
Nurse Practitioner
Johns Hopkins Kimmel Cancer Center
Baltimore, MD

Sylvia K. Wood, DNP, ANP-BC
Adult Nurse Practitioner
Associate Director
, BMT Clinical Research Program
Hematologic Malignancy Stem Cell Transplant Program
Stony Brook University Medical Center
Stony Brook, NY

Sponsors and Supporters

This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Millennium: The Takeda Oncology Company and Spectrum Pharmaceuticals.

last updated on Monday, July 15, 2013